CareGamers
Personal health and performance
Technological maturity
95%
TRL level
TRL 9
BRG-CG
- TRL 1
- TRL 2
- TRL 3
- TRL 4
- TRL 5
- TRL 6
- TRL 7
- TRL 8
- TRL 9
A product line for gamers, built to sustain performance and keep efficiency through long sessions.
The TRL scale
We do not use clinical trial phase nomenclature, which would be inappropriate for devices, software and cosmetic products. The TRL 1–9 scale describes technological maturity, from a basic principle observed to a system proven in a real operational environment.
- TRL 10–11%
- TRL 212–22%
- TRL 323–33%
- TRL 434–44%
- TRL 545–55%
- TRL 656–66%
- TRL 767–77%
- TRL 878–88%
- TRL 989–100%
- The TRL 1–9 scale measures the technological maturity of a programme: the percentage marks its position along that scale, not its distance from market entry. Programme status updated August 2026.
The problem. Prolonged gaming places specific demands on attention, eyesight, posture and emotional regulation. It is a recognisable, recurring condition of use that the generalist wellbeing offer is not designed for.
The BioRegenis solution. A product line dedicated to gamers, built to sustain performance, contain emotional swings and keep efficiency through long sessions.
State of progress.
Development — completed, 100%
Prototyping — completed, 100%
Finished products — completed, 100%
It is the most advanced programme in the portfolio: the products are defined and ready for distribution.
Next milestone. Consolidation of the distribution network in the target markets and first documented commercial results.
Expected applications. Distribution channels specialised in the gaming sector, in Italy and in Europe.
Intellectual property. The trademark is exclusively licensed to BioRegenis for classes 3 and 5.